Related Experiment Video
Updated: Jan 21, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Comparing the Modified History, Electrocardiogram, Age, Risk Factors, and Troponin Score and Coronary Artery Disease
Getu Teressa1, Varun Bhasin1, Pamela Noack2
1From the Department of Internal Medicine, Stony Brook Medicine, Stony Brook, NY.
Insights
The clinical coronary artery disease consortium (CADC) model better predicts obstructive coronary artery disease (CAD) than the HEART score. Both models effectively identify low-risk patients with minimal 30-day adverse cardiovascular events.
Area of Science:
- Cardiology
- Medical Diagnostics
- Risk Stratification
Background:
- Accurate prediction of obstructive coronary artery disease (CAD) is crucial for managing patients with acute chest pain.
- Existing risk assessment tools, such as the History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) score, require validation against newer models.
Purpose of the Study:
- To compare the predictive performance of the HEART score and the clinical coronary artery disease consortium (CADC) model.
- To evaluate their ability to identify obstructive CAD and predict 30-day major adverse cardiovascular events (MACE).
Main Methods:
- A study of 1981 patients with no known CAD presenting with acute chest pain and negative initial troponin/ECG.
- Classification of chest pain (typical, atypical, nonanginal) for the HEART score's history component.
- Comparison of C-statistics for predicting obstructive CAD and 30-day MACE using both models.
Main Results:
- The CADC model demonstrated a higher C-statistic for predicting obstructive CAD (0.792 vs. 0.747, P=0.0005).
- Both models showed similar performance in predicting 30-day MACE (C-statistics 0.850 for CADC vs. 0.820 for HEART, P=0.11).
- Both models effectively identified low-risk patients, with <1% 30-day MACE observed in patients predicted as low-risk by either score.
Conclusions:
- The CADC model is superior to the HEART score in predicting obstructive CAD.
- Both the HEART score and CADC model are effective in safely stratifying low-risk patients, minimizing 30-day MACE.
- These findings support the use of the CADC model for enhanced diagnostic accuracy in suspected CAD.
Abstract:
The objective of this study was to compare the History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) score and clinical coronary artery disease (CAD) consortium (CADC) model for predicting obstructive CAD (≥50% stenosis on coronary computed tomographic angiography) and 30-day major adverse cardiovascular events (MACE, composite of acute myocardial infarction, revascularization, and mortality). We studied 1981 patients with no known CAD who presented with acute chest pain and had negative initial troponin and electrocardiogram. Chest pain was classified as typical, atypical, and nonanginal and used to score the history component of the modified HEART score. The C-statistic for predicting obstructive CAD was 0.747 [95% confidence interval (CI), 0.712-0.783] for the HEART score and 0.792 (95% CI, 0.762-0.823) for the CADC model (P = 0.0005). The C-statistic for predicting 30-day MACE was 0.820 (95% CI, 0.774-0.864) for the HEART score and 0.850 (95% CI, 0.800-0.891) for the CADC model (P = 0.11). Among the 48.3% of patients for whom the CADC model predicted ≤5% probability of obstructive CAD, the observed 30-day MACE was 0.6%; among the 48.9% of patients for whom the HEART score was ≤2, the 30-day MACE was 0.6%. In conclusion, the CADC model was more effective at predicting obstructive CAD compared to the HEART score. The HEART score and CADC model were equally effective to safely identify low-risk patients by achieving <1% missed 30-day MACE.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease I: Introduction

